Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115998 · ClinicalTrials.gov registry record · Phase 2

Effect of Power Wheelchairs on the Development and Function of Young Children With Severe Physical Disabilities

A Phase 2 study, sponsored by University of Oklahoma.

Completed
Registry status
Phase 2
Development phase
34
Enrollment target

NCT01115998 is a Phase 2 study that has completed, run by University of Oklahoma. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01115998, a Phase 2 study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
Phase 2
Development phase
34 participants
Enrollment target

Study Summary

Self-produced locomotion often is limited in children with cerebral palsy and other conditions that cause severe motor impairments. As a result, these children may be at risk for secondary impairments in spatial cognition, communication, social development, and other domains influenced by independent mobility. To compensate, power mobility has increasingly been advocated for young children with severe motor impairments. The study hypotheses were: 1. Children with severe disabilities that prevent independent locomotion who learn to use power mobility devices when they are 14- to 30-months-of-age will have greater communication, social, and cognitive development over a 12-month period, and will demonstrate more competent coping skills than children with the same characteristics who do not use power mobility. 2. Parents of children who use power mobility will view it as a positive influence on their children's lives, and will perceive their children's development to be more mature than the parents of children who do not use power mobility will perceive their children's development.

Interventions

  • OTHER Power wheelchair
  • OTHER No power wheelchairs

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2002-06
Est. Completion 2004-12
Phase Phase 2

Sponsor

University of Oklahoma

358 total trials

What the Registry Record Tells You About NCT01115998

The ClinicalTrials.gov registry entry for NCT01115998 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Power wheelchair is the first listed.

NCT01115998 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01115998 about?

NCT01115998 is a clinical study titled "Effect of Power Wheelchairs on the Development and Function of Young Children With Severe Physical Disabilities". Self-produced locomotion often is limited in children with cerebral palsy and other conditions that cause severe motor impairments. As a result, these children may be at risk for secondary impairments in spatial cognition, communication, social development, and other domains influenced by independen...

What is the current status of trial NCT01115998?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2002-06. Estimated completion is 2004-12.

What interventions are being tested in trial NCT01115998?

The interventions under investigation include: Power wheelchair (OTHER), No power wheelchairs (OTHER).

Who is sponsoring clinical trial NCT01115998?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.